Division of Genetic Medicine and Clinical Pharmacology Archive — Page 9 of 12
-
November 18, 2021
Seven from VUMC among most highly cited researchers
Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers. -
October 21, 2021
Study links genetic variants, protein expression and human diseases
An international research team has developed a new resource that connects genetic variants and protein expression, which is expected to speed the identification of genes that cause disease — and point to novel treatment strategies. -
September 6, 2021
Medical diagnoses in musicians
Vanderbilt researchers mined electronic health records to find medical diagnoses that are more or less prevalent among musicians, who are present in large numbers in “Music City.” -
August 5, 2021
American Heart Association honors Biaggioni’s research
Italo Biaggioni, MD, professor of Medicine and Pharmacology, has been selected as a Distinguished Scientist of the American Heart Association for his contributions to cardiovascular and stroke research. -
July 22, 2021
For more precise drug treatments, ‘squeeze’ the genome: study finds
Large-scale studies will be required to identify the complexity of genetic variations that affect how patients respond to a given drug and whether they will have side effects, according to researchers at Vanderbilt University Medical Center. -
July 12, 2021
Probing statin-associated diseases with genetics
Vanderbilt researchers used genetics tools and biobanks with linked electronic health records to explore the associations between statins and noncardiovascular diseases. -
July 8, 2021
Study finds genetic risk factors for severe COVID-19 illness
A massive worldwide collaboration including researchers from Vanderbilt University Medical Center (VUMC) has identified several genetic factors associated with SARS-CoV-2 infection and severe COVID-19 illness.